000 01275 a2200337 4500
005 20250511214009.0
264 0 _c19920108
008 199201s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1991.tb03928.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoraes, M E
245 0 0 _aThe effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cOct 1991
300 _a441-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aKidney
_xmetabolism
650 0 4 _aMale
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aNifedipine
_xpharmacology
650 0 4 _aRenal Circulation
650 0 4 _aStrontium
_xpharmacokinetics
700 1 _aAronson, J K
700 1 _aGrahame-Smith, D G
773 0 _tBritish journal of clinical pharmacology
_gvol. 32
_gno. 4
_gp. 441-5
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1991.tb03928.x
_zAvailable from publisher's website
999 _c1964623
_d1964623